Tetanus Immune Globulin (Human) (Baytet, Hypertet)
Tetanus Immune Globulin (Human) is an FDA-licensed reference biologic from Grifols Therapeutics LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1957
Reference approved
Reference product
Baytet, Hypertet Tetanus Immune Globulin (Human)
Grifols Therapeutics LLC
- Approved
- Oct 17, 1957
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Tetanus Immune Globulin (Human), in chronological order.
Reference approval
Approval date of the reference Tetanus Immune Globulin (Human) product.
69 yr 7 mo ago
Frequently asked questions
Are there biosimilars approved for Tetanus Immune Globulin (Human) (Baytet, Hypertet)?
No 351(k) biosimilars or interchangeable biosimilars referencing Tetanus Immune Globulin (Human) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.